Zhong Xin Jia
Direttore operativo presso SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD.
Profilo
Zhong Xin Jia is currently the Chief Operating Officer at Sihuan Pharmaceutical Holdings Group Ltd.
She previously worked as the Chairman & CEO at Mayinglong Pharmaceutical Group Co., Ltd.
and held various Chairman positions at Shenzhen Pharmaceutical Factory, Xuanzhu Biopharmaceutical Co., Ltd., and TransThera Sciences (Nanjing), Inc. She also worked as the Head-Biomedical Department at China Baoan Group Co., Ltd.
Ms. Jia received her undergraduate degree from Peking University in 1982 and her MBA from the University of South Australia in 2004.
Posizioni attive di Zhong Xin Jia
| Società | Posizione | Inizio |
|---|---|---|
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. | Direttore operativo | 01/01/2007 |
Precedenti posizioni note di Zhong Xin Jia
| Società | Posizione | Fine |
|---|---|---|
| CHINA BAOAN GROUP CO., LTD. | Corporate Officer/Principal | 01/01/2007 |
| MAYINGLONG PHARMACEUTICAL GROUP CO., LTD. | Presidente | 01/01/2005 |
TransThera Sciences (Nanjing), Inc.
 TransThera Sciences (Nanjing), Inc. BiotechnologyHealth Technology TransThera Sciences (Nanjing), Inc. engages in the research and development of clinical biopharmaceutics. It focuses on the discovery and development of small molecule innovative therapies for tumors, inflammations, and cardiovascular diseases. The company was founded by Frank Wu on April 15, 2014 and is headquartered in Nanjing, China. | Direttore/Membro del Consiglio | - |
Xuanzhu Biopharmaceutical Co., Ltd.
 Xuanzhu Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xuanzhu Biopharmaceutical Co., Ltd. engages in the research and development of chemical and biological drugs. Its products include small molecular chemical drugs, monoclonal antibodies, bispecific antibodies, and antibody conjugated drugs. The company was founded in 2002 and is headquartered in Shijiazhuang, China. | Presidente | - |
Shenzhen Pharmaceutical Factory
 Shenzhen Pharmaceutical Factory Pharmaceuticals: OtherHealth Technology Part of Sinopharm Industrial Investment Co., Ltd., Shenzhen Pharmaceutical Factory engages in pharmaceuticals production. The company is based in Shenzhen, China. Shenzhen Pharmaceutical Factory was acquired by China National Accord Medicines Corp. Ltd. from Shenzhen City Investment Management Co. Ltd. on October 20, 2001 for $3.27 million. | Presidente | - |
Formazione di Zhong Xin Jia
| Peking University | Undergraduate Degree |
| University of South Australia | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. | Health Technology |
| MAYINGLONG PHARMACEUTICAL GROUP CO., LTD. | Health Technology |
| CHINA BAOAN GROUP CO., LTD. | Producer Manufacturing |
| Aziende private | 3 |
|---|---|
Shenzhen Pharmaceutical Factory
Shenzhen Pharmaceutical Factory Pharmaceuticals: OtherHealth Technology Part of Sinopharm Industrial Investment Co., Ltd., Shenzhen Pharmaceutical Factory engages in pharmaceuticals production. The company is based in Shenzhen, China. Shenzhen Pharmaceutical Factory was acquired by China National Accord Medicines Corp. Ltd. from Shenzhen City Investment Management Co. Ltd. on October 20, 2001 for $3.27 million. | Health Technology |
Xuanzhu Biopharmaceutical Co., Ltd.
Xuanzhu Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xuanzhu Biopharmaceutical Co., Ltd. engages in the research and development of chemical and biological drugs. Its products include small molecular chemical drugs, monoclonal antibodies, bispecific antibodies, and antibody conjugated drugs. The company was founded in 2002 and is headquartered in Shijiazhuang, China. | Commercial Services |
TransThera Sciences (Nanjing), Inc.
TransThera Sciences (Nanjing), Inc. BiotechnologyHealth Technology TransThera Sciences (Nanjing), Inc. engages in the research and development of clinical biopharmaceutics. It focuses on the discovery and development of small molecule innovative therapies for tumors, inflammations, and cardiovascular diseases. The company was founded by Frank Wu on April 15, 2014 and is headquartered in Nanjing, China. | Health Technology |
- Borsa valori
- Insiders
- Zhong Xin Jia
